M&A Deal Summary

JLL Partners and Water Street Healthcare Partners Acquire EVERSANA

On October 1, 2018, private equity firms JLL Partners and Water Street Healthcare Partners acquired life science company EVERSANA

Acquisition Highlights
  • This is JLL Partners’ 6th and Water Street Healthcare Partners’ 9th transaction in the Life Science sector.
  • This is JLL Partners’ 29th and Water Street Healthcare Partners’ 34th transaction in the United States.
  • This is JLL Partners’ 1st and Water Street Healthcare Partners’ 1st transaction in Wisconsin.

M&A Deal Summary
Date 2018-10-01
Target EVERSANA
Sector Life Science
Buyer(s) JLL Partners
Water Street Healthcare Partners
Deal Type Consolidation

Target

EVERSANA

Milwaukee, Wisconsin, United States
EVERSANA's corporate headquarters in Milwaukee, Wisconsin.
EVERSANA's corporate headquarters in Milwaukee, Wisconsin.
EVERSANA combines global life science services into an integrated, independent and intelligent commercialization platform. With services rooted in the patient experience and spanning global pricing, market access, marketing, patient support, channel distribution, and consulting, the company creates value for patients, prescribers, and payers at all stages of the product lifecycle. EVERSANA is based in Milwaukee, Wisconsin.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

JLL Partners

New York, New York, United States

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1988
PE ASSETS 5.8B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

JLL Partners, Inc. is a private equity investment firm that invests alongside management in middle-market companies. JLL prefers control investments in sectors such as healthcare services, medical products, food and consumer products, chemicals, broadcasting, transportation, automotive, industrial manufacturing, and distribution. In addition to traditional buyout transaction, JLL also seeks distressed/turnaround situations. JLL Partners was formed in 1988 and is based in New York City.

DEAL STATS #
Overall 30 of 40
Sector (Life Science) 6 of 7
Type (Consolidation) 2 of 2
State (Wisconsin) 1 of 1
Country (United States) 29 of 38
Year (2018) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-01 Triplefin

Cincinnati, Ohio, United States

Triplefin LLC is a provider of integrated business process outsourcing solutions to pharmaceutical and consumer products companies. Triplefin delivers comprehensive hub services that improve patient access and adherence, including its patent-pending Rx365® suite of digital solutions. Triplefin’s programs help thousands of patients with serious diseases, offering hope and improved well-being. Its associates are dedicated to providing an empathetic, caring experience throughout a patient’s journey. The company is headquartered in Cincinnati, Ohio.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-28 Allucent

Cary, North Carolina, United States

Allucent is a provider of solutions that support life science organizations with advancing drug development. Allucent offers a range of services including regulatory strategy and submissions, project management, medical writing, biostatistics, data management, pharmacokinetics, pharmacovigilance, quality assurance, and trial management. Allucent was founded in 1988 and is based in Cary, North Carolina.

Buy -
Buyer

Water Street Healthcare Partners

Chicago, Illinois, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2005
PE ASSETS 6.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Water Street is a specialist private equity firm that targets investments in healthcare companies. Specific areas of interest within healthcare include diagnostic devices, medical products, pharmaceutical services, specialty distribution, specialty pharmaceuticals, and specialty services. Water Street targets non-core units of larger corporations and private middle-market companies. Transactions are typically valued between $50 and $500 million. Water Street does not invest in biotechnology, traditional healthcare facilities (hospitals, nursing homes) or early-stage companies without positive cash flow. Water Street was formed in 2005 and is based in Chicago, Illinois.

DEAL STATS #
Overall 35 of 50
Sector (Life Science) 9 of 12
Type (Consolidation) 2 of 4
State (Wisconsin) 1 of 1
Country (United States) 34 of 47
Year (2018) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-01 Triplefin

Cincinnati, Ohio, United States

Triplefin LLC is a provider of integrated business process outsourcing solutions to pharmaceutical and consumer products companies. Triplefin delivers comprehensive hub services that improve patient access and adherence, including its patent-pending Rx365® suite of digital solutions. Triplefin’s programs help thousands of patients with serious diseases, offering hope and improved well-being. Its associates are dedicated to providing an empathetic, caring experience throughout a patient’s journey. The company is headquartered in Cincinnati, Ohio.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-16 Discovery Life Sciences

Huntsville, Alabama, United States

Discovery Life Sciences is a provider of biospecimen analysis, procurement, distribution, and genomic, cell-based and histology-based scientific services for the pharmaceutical, biotechnology, and diagnostics industries. HudsonAlpha Discovery is Discovery’s sequencing and bioinformatics division, a globally recognized service laboratory that leverages the most current genomic research technologies to comprehensively support discovery, translational, and clinical research. Discovery Life Sciences was founded in 2018 and is based in Huntsville, Alabama.

Buy -
Mergr

Product

Company

Legal